Immunotherapy

The novel immunotherapy approach uses bispecific antibodies against mutant proteins to target cancer cells

This is the first randomized study to report on the role of combination checkpoint inhibitors for early stage NSCLC

Study shows how chemicals in the tumor microenvironment subvert the immune system, enabling cancer to evade attack

The biomarkers could help discriminate treatment-associated kidney injury from other causes, guiding treatment

As cell culture has gained more importance in research, it has evolved—and the incubator has evolved along with it 

The results help explain why some tumors do not respond to immunotherapy and suggest ways to improve it

New research identified a type of immune cell that promotes breast cancer growth by preventing anti-tumor responses

Genomic heterogeneity in tumors can also be exploited to identify patient subsets that may benefit from targeted treatment strategies

The study is one of the first to demonstrate CAR T-cells achieving rapid regression against a solid cancer

The new advanced microscopy platform can identify the immune checkpoints that buffer the anti-tumor response